Nexalin Technology Provides 2022 Year-End Business Update
27 mars 2023 07h00 HE
|
Nexalin Technology, Inc.
HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today provided a business update for the year ended December 31, 2022. Mark...
Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory
24 janv. 2023 08h30 HE
|
Nexalin Technology, Inc.
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today announced the appointment of Michael Nketiah as Senior Vice President of...
Nexalin Technology CEO Provides Letter to Shareholders
05 janv. 2023 08h30 HE
|
Nexalin Technology, Inc.
HOUSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today provided the following business update and letter to shareholders from...
Nexalin Technology Announces Publication of a White Paper Validating its tACS Device for the Treatment of Generalized Anxiety Disorder
14 nov. 2022 14h00 HE
|
Nexalin Technology, Inc.
The Second Xiangya Hospital of Central South University, China, reports positive patient results, including disappearance of all somatic anxiety symptoms and improved quality of sleep Treatment...
Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial Public Offering
20 sept. 2022 13h12 HE
|
Nexalin Technology, Inc.
HOUSTON, TEXAS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) today announced the closing of its previously announced initial public offering of 2,315,000...
Nexalin Technology, Inc. Announces Pricing of $9.6 Million Initial Public Offering
15 sept. 2022 20h54 HE
|
Nexalin Technology, Inc.
HOUSTON, TEXAS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) today announced the pricing of its initial public offering of 2,315,000 units consisting of...